Literature DB >> 9085557

Varying effects of cyclodextrin derivatives on aggregation and thermal behavior of insulin in aqueous solution.

K Tokihiro1, T Irie, K Uekama.   

Abstract

Maltosyl-beta-cyclodextrin (G2-beta-CyD) suppressed the aggregation of insulin in neutral solution, while the sulfate of beta-CyD (S-beta-CyD) accelerated the aggregation. On the other hand, the sulfobutyl ether of beta-CyD (SBE-beta-CyD) showed varying effects on insulin aggregation, depending on the degree of substitution of the sulfobutyl group: i.e., the inhibition at relatively low substitution and acceleration at higher substitution. Differential scanning calorimetric studies indicate that the self-association of insulin stabilized the native conformation of the peptide, as indicated by an increase in the mean unfolding temperature (Tm). G2-beta-CyD and SBE-beta-CyD decreased the Tm value of insulin oligomers, while S-beta-CyD increased the Tm value. 1H-Nuclear magnetic resonance spectroscopic studies suggest that G2-beta-CyD includes accessible hydrophobic side chains of insulin within the CyD cavity, and hence perturbs the intermolecular hydrophobic contacts between aromatic side chains across the monomer-monomer interfaces. By contrast, the electrostatic interaction between the positive charges of insulin and the concentrated negative charges of the sulfate and sulfonate groups of the anionic beta-CyDs seems to be more of a factor than the inclusion effects. These results suggest proper use of the CyD derivatives could be effective in designing rapid or long-acting insulin preparations.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9085557     DOI: 10.1248/cpb.45.525

Source DB:  PubMed          Journal:  Chem Pharm Bull (Tokyo)        ISSN: 0009-2363            Impact factor:   1.645


  8 in total

Review 1.  Stability of protein pharmaceuticals: an update.

Authors:  Mark Cornell Manning; Danny K Chou; Brian M Murphy; Robert W Payne; Derrick S Katayama
Journal:  Pharm Res       Date:  2010-02-09       Impact factor: 4.200

2.  Mutual inhibition of the insulin absorption-enhancing properties of dodecylmaltoside and dimethyl-beta-cyclodextrin following nasal administration.

Authors:  F Ahsan; J J Arnold; E Meezan; D J Pillion
Journal:  Pharm Res       Date:  2001-05       Impact factor: 4.200

3.  A central composite design to investigate the thermal stabilization of lysozyme.

Authors:  S Branchu; R T Forbes; P York; H Nyqvist
Journal:  Pharm Res       Date:  1999-05       Impact factor: 4.200

Review 4.  Cyclodextrins in drug delivery: an updated review.

Authors:  Rajeswari Challa; Alka Ahuja; Javed Ali; R K Khar
Journal:  AAPS PharmSciTech       Date:  2005-10-14       Impact factor: 3.246

5.  Effects of hydrophilic cyclodextrins on aggregation of recombinant human growth hormone.

Authors:  Sumitra Tavornvipas; Shinichiro Tajiri; Fumitoshi Hirayama; Hidetoshi Arima; Kaneto Uekama
Journal:  Pharm Res       Date:  2004-12       Impact factor: 4.200

6.  Structural basis for cyclodextrins' suppression of human growth hormone aggregation.

Authors:  Daniel Erik Otzen; Benjamin Raerup Knudsen; Finn Aachmann; Kim Lambertsen Larsen; Reinhard Wimmer
Journal:  Protein Sci       Date:  2002-07       Impact factor: 6.725

7.  Pulmonary absorption of insulin mediated by tetradecyl-beta-maltoside and dimethyl-beta-cyclodextrin.

Authors:  Alamdar Hussain; Tianzhi Yang; Abdel-Azim Zaghloul; Fakhrul Ahsan
Journal:  Pharm Res       Date:  2003-10       Impact factor: 4.200

8.  Effects of Selected Anionic β-Cyclodextrins on Persistence of Blood Glucose Lowering by Insulin Glargine after Subcutaneous Injection to Rats.

Authors:  Keiko Uehata; Takayuki Anno; Kayoko Hayashida; Keiichi Motoyama; Taishi Higashi; Fumitoshi Hirayama; Naomi Ono; James D Pipkin; Kaneto Uekama; Hidetoshi Arima
Journal:  J Drug Deliv       Date:  2011-12-11
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.